AcuityMD Expands AI Tools for MedTech Sales Enhancement
AcuityMD has announced a significant expansion of its AI platform, aimed at enhancing sales performance for medical device companies. The announcement was made at the company's annual Flywheel event, where new AI tools were introduced to provide better visibility into forecasted sales performance, business risks, and strategic actions.
The platform's new capabilities are designed to address challenges faced by MedTech commercial teams, such as fragmented tools and incomplete data, which hinder accurate forecasting and opportunity prioritization. AcuityMD's enhanced AI tools offer reliable forecasts and AI-driven action plans to help leaders focus resources effectively and accelerate revenue growth.
Key features of the expanded platform include generative next-best actions, MedTech-specific forecasting, and an AI voice assistant. These tools guide sales representatives to high-value opportunities, enable precise strategic planning, and convert field observations into structured insights, respectively. The AI recommendation engine continuously learns from interactions, providing smarter and more personalized guidance over time.
The expansion is built on AcuityMD's foundation of real-world market data and advanced targeting technology, offering a powerful layer of insights and guided execution that adapts and improves continuously.
We hope you enjoyed this article
Consider subscribing to one of our newsletters like Life AI Weekly or Daily AI Brief.
Also, consider following us on social media:
More from Life Sciences
Sep 22 Aqurio Named Finalist for 2026 AI Startup of the Year Sep 22 Tsingke Introduces Validation Workflow for AI Designed Proteins Sep 22 QC Healthcare Partners With Sanguina for AI Blood Health Screening Sep 22 RIVANNA Files 100th Patent for Ultrasound AI Sep 22 Ultima Genomics Platform Selected for Precure's One Million Sample DatasetLife AI Weekly
Weekly coverage of AI applications in healthcare, drug development, biotechnology research, and genomics breakthroughs.
Industry analysis
2025 Global Business Services Agenda: Gen AI Takes Center Stage
This industry analysis by The Hackett Group explores the transformative impact of generative artificial intelligence (Gen AI) on global business services (GBS) in 2025. The study highlights the shift from exploration to acceleration of Gen AI initiatives, with 89% of executives advancing these projects to improve customer satisfaction, innovate products, and reduce costs. The report also discusses the challenges and strategies for successful Gen AI adoption, emphasizing the need for a technology-enabled operating model and the importance of reskilling the workforce.
Read moreYou may also like
SalesSparx and Augment Release SAMI.ai for Healthcare Sales Teams
UT Medical and TransformativeMed Build Agentic AI Discharge Planning Tool
Milliman MedInsight Introduces MIKE for Healthcare Analytics
I-care Acquires Amiral Technologies for Predictive Maintenance AI
Acquis Launches AI Integration Platform AcquisLink
Daily AI Brief: the AI news that matters, in your inbox.